In financial accounting, a balance sheet is a summary of the financial balances of an individual or organization, whether it be a sole proprietorship, a business partnership, a corporation, private limited company or other organization such as government or not-for-profit entity.
Sino Biopharmaceutical Limited Balance Sheet Statement - Assets
As of 31 Dec 2021, The total current assets of Sino Biopharmaceutical Limited (HKEX:1177) was around ¥23,503,178,000 which consisted of ¥10,568,812,000 of Cash, ¥1,937,741,000 of Inventory and ¥5,537,259,000 of Net receivables. Current assets represent all the assets of a company that are expected to be conveniently sold, consumed, used, or exhausted through standard business operations within one year.
All amounts in CNY
The latest balance sheet of Sino Biopharmaceutical Limited also showed ¥8,516,062,000 of Property Plant Equipment and ¥647,930,000 of Good will. Also there were ¥291,557,000 of Intangible assets and ¥2,415,125,000 of Other assets. The total assets including current and Intangibles/Deferred Long Term Asset Charges were ¥60,543,337,000.
Sino Biopharmaceutical Limited Balance Sheet Statement - Liabilities
1177's latest annual results shows the balance sheet has ¥1,693,152,000 of Accounts Payable. Also there were ¥6,520,565,000 of Short/Long term debt, ¥5,212,526,000 of Long term debt, ¥1,920,989,000 of Other Current liabilities and ¥15,345,019,000 of Total Current Liabilities. Current liabilities are a company's short-term financial obligations that are due within one year or within a normal operating cycle.
As per the 31 Dec 2021's annual report of Sino Biopharmaceutical Limited, the total liabilities were ¥22,814,314,000.
1177 Balance Sheet Statement - Stock Holder Equity
Stockholders' equity, also referred to as shareholders' equity, is the remaining amount of assets available to shareholders after all liabilities have been paid. It is calculated either as a firm's total assets less its total liabilities or alternatively as the sum of share capital and retained earnings less treasury shares. Stockholders' equity might include common stock, paid-in capital, retained earnings and treasury stock.
The latest Balance sheet of Sino Biopharmaceutical Limited showed the total stock holder equity was ¥30,291,116,000 which consisted of ¥415,440,000 of Common stocks, ¥27,214,610,000 of Retained earnings and ¥-9,227,928,000 of Other stock holder equity.
1177 Balance Sheet Statement History
Following table shows the history of balance sheet for Sino Biopharmaceutical Limited (1177).
|31 Dec 2021||31 Dec 2020||31 Dec 2019||31 Dec 2018|
|Total Current Assets||23.5B||22.79B||24.91B||18.54B|
|Property Plant Equipment||8.52B||8.39B||7.63B||5.8B|
|Deferred Long Term Asset Charges||334.87M||463.37M||557.35M||470.56M|
|Short/Long Term Debt||6.52B||1.55B||22.13M||48.11M|
|Other Current Liabilities||1.92B||3.22B||2.06B||1.68B|
|Long Term Debt||5.21B||12.36B||7.88B||507.07M|
|Total Current Liabilities||15.35B||10.94B||8.12B||9.67B|
|Other Stockholder Equity||-9.23B||-9.49B||-9.83B||-462.85M|
|Total Stockholder Equity||30.29B||16.75B||14.95B||29.21B|
|Net Tangible Assets||29.35B||16.43B||14.04B||7.47B|
Sino Biopharmaceutical Limited (HKEX:1177) Balance Sheet Statement FAQ
1. How much Cash Sino Biopharmaceutical Limited has on their balance sheet?
As of 31 Dec 2021, Sino Biopharmaceutical Limited (HKEX:1177) has ¥10,568,812,000 of Cash.
2. What's the long term debt of Sino Biopharmaceutical Limited?
As per the latest Balance sheet of Sino Biopharmaceutical Limited (HKEX:1177), it has ¥5,212,526,000 of Long term debt.
3. How much share holder equity does Sino Biopharmaceutical Limited has?
The Sino Biopharmaceutical Limited (HKEX:1177)'s balance sheet shows that it has ¥30,291,116,000 of Total stock holder equity.